Navigation Links
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Date:10/16/2009

at the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

US.RAS.09.09.009

Contact: Madeline Malia, sanofi-aventis U.S., (908) 981-5687, madeline.malia@sanofi-aventis.com

SOURCE sanofi-aventis


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
2. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
3. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
4. FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
5. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
6. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
7. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
8. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
9. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
10. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
11. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2012)... 10, 2012 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it ... Conference on Monday, February 27, 2012, in New York. ... Financial Officer, will speak at 11:00 AM Eastern Time.  ... accessed by clicking on the Investor Relations link on ...
(Date:2/10/2012)... 10, 2012  Viztek, the digital radiology solution ... DR U-Arm at Edison Metuchen Orthopaedic Group (EMOG) ... surgeons and a psychiatrist with onsite x-ray and access ... in the same building. EMOG performs ... previously used two traditional analog x-ray rooms to ...
(Date:2/10/2012)... Children and adolescents with obstructive sleep apnea had ... life after treatment with positive airway pressure (PAP)—a ... stream of air through a mask into the ... when children didn,t fully adhere to the treatment," ... sleep specialist and director of the Sleep Center ...
Breaking Medicine Technology:Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 2Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 3Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 1Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 1Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 3Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 4Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 5Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 6Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3
... Amicus Therapeutics (Nasdaq: FOLD ) today announced ... No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods of ... isofagomine, the active ingredient in the Company,s investigational drug Plicera(TM) ... disease. The patent will expire in 2027. John ...
... reduces abdominal pain and bloating CLEVELAND, March 24 ... Postgraduate Medicine found that a strain of probiotic bacteria, ... abdominal pain and bloating in subjects with irritable bowel ... percent of the U.S. population suffer from IBS, a condition ...
Other Medicine Technology:Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 2Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 2New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 4
(Date:2/10/2012)... HealthDay Reporter , , THURSDAY, Feb. 9 (HealthDay ... after using marijuana nearly doubles a driver,s risk of ... The risk is especially high for fatal crashes, ... that of people who drive drunk, Canadian researchers say. ... a crash at a higher level than cannabis [marijuana]," ...
(Date:2/10/2012)... the 2012 Annual Meeting of the American Academy ... 4.5 million Americans are living with a total ... surgeries has more than doubled over the past ... Osteoarthritis continues to be the primary reason for ... data; information from the National Health Interview Survey, ...
(Date:2/9/2012)... (February 10, 2012) In a study to be ... meeting, The Pregnancy Meeting , in Dallas, Texas, researchers ... stem cells into the lateral ventricles of neonatal rats ... donor cells can survive and migrate in the recipient,s ... rat,s brain damage mimic brain injury in infants with ...
(Date:2/9/2012)... In a study to be presented today at the ... , in Dallas, Texas, researchers will report findings that ... for women who deliver or intend to deliver outside ... newborns intended for home births compared to hospital births. ... of Birth: Birth Centers and Home Birth Compared to ...
(Date:2/9/2012)... sleep apnea had substantial improvements in attention, anxiety and ... (PAP)a nighttime therapy in which a machine delivers a ... , "The benefits occurred even when children didn,t ... L. Marcus, M.D., a sleep specialist and director of ... The Sleep Center follows thousands of children and adolescents ...
Breaking Medicine News(10 mins):Health News:Pot Use Could Double Risk of Car Crash, Research Shows 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 3Health News:Pot Use Could Double Risk of Car Crash, Research Shows 4Health News:4.5 million Americans living with total knee replacement 2Health News:Neurologic improvement detected in rats receiving stem cell transplant 2Health News:Sleep breathing machine shows clear benefits in children with sleep apnea 2
... need to be cut out of system in coming ... health-care reform becomes a reality, most Americans can expect ... 2016, a new report claims. , Left unchecked, the ... to $24,291 in the next seven years, according to ...
... HIMSS Explains Three Reasons to Support Pres. Obama,s Call ... 28 The Healthcare Information and Management Systems Society ... which 73% work in provider settings -- and 350 ... information technology (IT) provisions in the American Recovery and ...
... MIAMI, Jan. 28 Independent Living Systems, LLC (ILS), ... populations,with chronic care and other special care needs, announced ... vice president of long-term,care. In this role, Carbonell will ... fortifying its focus and commitment to servicing the,growing Florida ...
... new treatments for the neurological disorder , , WEDNESDAY, Jan. ... variation to a common form of epilepsy in children, ... disorder. , "It,s the first step toward developing a ... diagnosis and information about which particular drug or treatment ...
... 28 Noteworthy Medical Systems, Inc.,announced a ... of Idaho (MRI) and the Idaho Association ... information exchange for providers in,southeastern Idaho. Portneuf ... in eastern Idaho for advanced patient care; ...
... of certain proteins in the spinal fluid could signal ... The discovery of these biomarkers may lead to diagnostic ... the disease and monitoring the effects of treatment., Lou ... is caused by the degeneration of nerve cells controlling ...
Other Medicine News:Health News:Skyrocketing Health-Care Costs Could Double Premiums for Many Americans 2Health News:Skyrocketing Health-Care Costs Could Double Premiums for Many Americans 3Health News:Electronic Health Records: The Time is Now 2Health News:Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems 2Health News:Gene Discovered for Most Common Form of Epilepsy 2Health News:Collaborative Medicine Soon a Reality for Providers in Southeastern Idaho 2Health News:Collaborative Medicine Soon a Reality for Providers in Southeastern Idaho 3Health News:Collaborative Medicine Soon a Reality for Providers in Southeastern Idaho 4Health News:Spinal fluid proteins signal Lou Gehrig's disease 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: